Ameritas Investment Partners’s Imago BioSciences, Inc. Common stock IMGO Stock Holding History

Ameritas Investment Partners’s Portfolio IMGO Stock Details IMGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-1,556	Closed	-$23K	–	3055
2022 Q3	$23K	Hold	1,556	–	–	﹤0.01%	2475
2022 Q2	$20K	Hold	1,556	–	–	﹤0.01%	2553
2022 Q1	$30K	Buy	1,556 +809	+108%	+$16.8K	﹤0.01%	2376
2021 Q4	$18K	Hold	747	–	–	﹤0.01%	2700
2021 Q3	$15K	Buy	+747	New	+$16K	﹤0.01%	2833

Other funds holding IMGO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

FLSM

Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

OFM

Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return

Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Versor Investments New York $40.8M AUM 93.59% 1-Year Est. Return

TAL

TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

Ameritas Investment Partners's IMGO Position: Q4 2022 in Review

Ameritas Investment Partners sold out of Imago BioSciences, Inc. Common stock (IMGO) in Q4 2022, closing a stake of 1,556 shares — an estimated $23K sold.

Ameritas Investment Partners first reported a position in IMGO in Q3 2021 and held it in 5 quarters. The position peaked at $30K in Q1 2022. 106 funds tracked by Wall St. Rank hold IMGO as of Q4 2022.

Ameritas Investment Partners reported no remaining Imago BioSciences, Inc. Common stock position as of Q4 2022 after selling out during the quarter.
Ameritas Investment Partners sold 1,556 Imago BioSciences, Inc. Common stock shares in Q4 2022, an estimated $23K.
Ameritas Investment Partners first reported a position in Imago BioSciences, Inc. Common stock in Q3 2021 and held it in 5 quarters.
Ameritas Investment Partners's Imago BioSciences, Inc. Common stock position peaked at $30K in Q1 2022.
106 funds tracked by Wall St. Rank held Imago BioSciences, Inc. Common stock as of Q4 2022.

Based on Ameritas Investment Partners's 13F filing for Q4 2022, filed 13 Feb 2023.